drugset / Trial / NCT02496585

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

NCT02496585

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to find out what effects, good and/or bad, the drug nintedanib in combination with steroids, has on the lungs. Furthermore, such treatments' side effects will be studied together with quality of life. In addition, the investigators would like to determine whether they can find markers in the blood which predict worsening lung injury.

Timeline

Start
2015-07-08
Primary completion
2024-04-12
Completion
2024-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nintedanib Small molecule 150 mg Oral
Background Prednisone Other / unclassified 10 mg

Indications